Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

There are instances where high-yielding stocks can simply be great deals. Three stocks that pay at least 6% and don't look ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

Below is some historical data on the post-earnings performance of Pfizer stock compared to the stock performance of peers that reported their earnings just before Pfizer. For a fair comparison ...

Pfizer PFE will report its first-quarter earnings ... The healthcare bellwether’s performance has been solid, with the company exceeding earnings expectations in each of the trailing four ...

Here is some historical data on the past post-earnings performance of Pfizer stock compared with the stock performance of peers that reported earnings just before Pfizer. For fair comparison ...

UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...